ArticleRMD open2023

Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.

Corrado Campochiaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.